We are live on ! Find out more
CBIO

Crescent Biopharma

84 hedge funds and large institutions have $707M invested in Crescent Biopharma in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $6.31M | Put options by funds: $2.06M

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

32% more capital invested

Capital invested by funds: $535M → $707M (+$171M)

23% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 22

5% more funds holding

Funds holding: 8084 (+4)

0.13% more ownership

Funds ownership: 0.93%1.06% (+0.13%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
33
Reduced
16
Closed
22
Calls
$6.31M
Puts
$2.06M
Net Calls
+$4.24M
Net Calls Change
+$6.06M
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
101
SG Americas Securities
New York
-$103K -62 Closed
Federated Hermes
102
Federated Hermes
Pennsylvania
-$16K -9 Closed
CIBC Private Wealth Group
103
CIBC Private Wealth Group
Georgia
-$13K -8 Closed
PO
104
Private Ocean
California
-$8K -5 Closed
RFM
105
Royal Fund Management
Florida
-$6K -4 Closed
MAM
106
Meeder Asset Management
Ohio
-$1K -1 Closed